×
About 455 results

ALLMedicine™ Acute Bronchospasm Center

Research & Reviews  37 results

Theophylline Level 
https://emedicine.medscape.com/article/2090395-overview

Feb 9th, 2020 - Reference Range Theophylline is a methylxanthine, a class of molecule similar to the xanthines caffeine and theobromine found in a normal diet. [1, 2] It has a half-life of 8 hours in a healthy person but decreases to 4-5 hours in people who smoke...

Theophylline Level 
https://emedicine.medscape.com/article/2090395-print

Feb 9th, 2020 - Theophylline is a methylxanthine, a class of molecule similar to the xanthines caffeine and theobromine found in a normal diet.[1, 2] It has a half-life of 8 hours in a healthy person but decreases to 4-5 hours in people who smoke.[3] In the blood...

Tissue traction microscopy to quantify muscle contraction within precision-cut lung sli...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052683
American Journal of Physiology. Lung Cellular and Molecular Physiology; Ram-Mohan S, Bai Y et. al.

Nov 27th, 2019 - In asthma, acute bronchospasm is driven by contractile forces of airway smooth muscle (ASM). These forces can be imaged in the cultured ASM cell or assessed in the muscle strip and the tracheal/bronchial ring, but in each case, the ASM is studied ...

FDA approves benralizumab autoinjector for eosinophilic asthma
https://www.mdedge.com/pulmonary-health-hub/article/209478/asthma/fda-approves-benralizumab-autoinjector-eosinophilic?channel=94
Christopher Palmer

Oct 4th, 2019 - The Food and Drug Administration has approved a prefilled, single-use autoinjector of benralizumab (Fasenra) for self-administration in adults with eosinophilic asthma, according to a press release from AstraZeneca. Benralizumab is already approve.

Incidence of acute bronchospasm during systemic adenosine administration for coronary a...
https://doi.org/10.4997/JRCPE.2019.307
The Journal of the Royal College of Physicians of Edinburgh; Morrow A, Ford TJ et. al.

Sep 9th, 2019 - Adenosine is frequently used during coronary angiography to induce hyperaemia and allow operators to perform quantitative measurements of lesion severity. Acute bronchospasm is a recognised side effect relating to the activation of 'off target' A2...

see more →

Guidelines  1 results

NUCALA (mepolizumab) For Severe Eosinophilic Asthma
https://gskpro.com/en-us/products/nucala

NUCALA is indicated for the add-on maintenance treatment of patients 12 years and older with severe asthma with an eosinophilic phenotype. NUCALA is not indicated for the relief of acute bronchospasm or status asthmaticus.

see more →

Drugs  185 results see all →

Clinicaltrials.gov  229 results

Trelegy ellipta - fluticasone furoate, umeclidinium bromide and vilanterol trifenatate powder-GlaxoSmithKline LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b5a81d5a-4648-4c7a-951d-33c014a63c7e

Sep 8th, 2020 - TRELEGY ELLIPTA is a combination of fluticasone furoate, an inhaled corticosteroid (ICS); umeclidinium, an anticholinergic; and vilanterol, a long-acting beta2-adrenergic agonist (LABA), indicated for: •the maintenance treatment of patients with c...

Dulera - mometasone furoate and formoterol fumarate dihydrate aerosol-Merck Sharp & Dohme Corp.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=116464ce-cfd8-4b9f-8b5a-3a114b6ff2b1

Aug 2nd, 2020 - DULERA is a combination product containing a corticosteroid and a long-acting beta2-adrenergic agonist (LABA) indicated for: Treatment of asthma in patients 5 years of age and older. (1.1) Important Limitation of Use: Not indicated for the relief ...

Asmanex hfa - mometasone furoate aerosol-Merck Sharp & Dohme Corp.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1f608abd-d414-41e9-89bd-32dd2ef33cb8

Aug 2nd, 2020 - ASMANEX HFA is a corticosteroid indicated for: Maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. (1.1) Important limitations: Not indicated for the relief of acute bronchospasm. (1.1) ASMANEX® HFA is ind...

Breztri - budesonide, glycopyrrolate, and formoterol fumarate aerosol, metered-AstraZeneca Pharmaceuticals LP
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=715433dc-cb2b-43ea-b6df-c5b4177adc6c

Jul 22nd, 2020 - BREZTRI AEROSPHERE is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Limitations of Use: BREZTRI AEROSPHERE is not indicated for the relief of acute bronchospasm or for the treatment of asthm...

Flovent hfa - fluticasone propionate aerosol, metered-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=74563f7b-8512-4b76-8c55-b88b9cd3206b

Jul 12th, 2020 - FLOVENT HFA is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older. Important Limitation of Use Flovent HFA is not indicated for the relief of acute bronchospasm. FLOVENT HFA is an inhaled c...

see more →

News  3 results

FDA approves benralizumab autoinjector for eosinophilic asthma
https://www.mdedge.com/pulmonary-health-hub/article/209478/asthma/fda-approves-benralizumab-autoinjector-eosinophilic?channel=94
Christopher Palmer

Oct 4th, 2019 - The Food and Drug Administration has approved a prefilled, single-use autoinjector of benralizumab (Fasenra) for self-administration in adults with eosinophilic asthma, according to a press release from AstraZeneca. Benralizumab is already approve.

FDA Approves Long-Acting COPD Inhaler
https://www.medpagetoday.com/pulmonology/smokingcopd/47038

Aug 1st, 2014 - The FDA approved another once-daily bronchodilator, olodaterol (Striverdi Respimat), for maintenance treatment of chronic obstructive pulmonary disease (COPD). Approved indications for the long-acting beta-adrenergic agonist (LABA) drug included l...

NUCALA (mepolizumab) For Severe Eosinophilic Asthma
https://gskpro.com/en-us/products/nucala

NUCALA is indicated for the add-on maintenance treatment of patients 12 years and older with severe asthma with an eosinophilic phenotype. NUCALA is not indicated for the relief of acute bronchospasm or status asthmaticus.

see more →